Fact CheckerSign in

NCT06507150Recruiting

AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance

Source: ClinicalTrials.gov · Last updated 12 Mar 2026

Brief summary (registry, in English)

Migraine affects 1 in 7 people globally, significantly impacting quality of life and economic productivity. Despite its prevalence, limited awareness leads to misdiagnosis, inadequate treatment, and stigmatization. AI can enhance migraine management through improved diagnosis, prediction, and personalized education. The primary objective of this study is to determine if adding AI-assisted migraine education to standard education improves patients' understanding of their condition more effectively.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
140 (estimated)
First submitted
4 Jul 2024
Start date
1 Sept 2024
Primary completion date
30 Jun 2027
Lead sponsor
Ente Ospedaliero Cantonale, Bellinzona
Diseases
Migraine
NCT number
NCT06507150

What you commit to

  • Study type: Interventional
  • Planned participants: 140
  • From 1 Sept 2024 to the primary completion date, 30 Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with cognitive impairment and/or unable to use or access the AI-powered learning platform developed in this study.

Other

  • Insufficient knowledge of the protocol language (italian)
  • Vulnerable participants (e.g. minors, participants incapable of judgment or participants under tutelage)

Who the study is looking for

  • aged between 18 and 65 years at the time of signing the informed consent
  • Newly diagnosis of migraine, confirmed through the medical chart
  • The participant must be capable of giving signed informed consent
  • Access to a laptop, computer, smartphone, or tablet

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ente Ospedaliero Cantonale - Ospedale Regionale di Lugano
Coordinator of this site? Confirm its status
LuganoSwitzerlandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.